Pharmacological treatment of diabetic neuropathic pain (Q37858519)

24 August 2017

1 reference

title

Pharmacological treatment of diabetic neuropathic pain (English)

1 reference

24 August 2017

0 references

1 reference

Howard S Smith

1

1 reference

PubMed ID

21443281

24 August 2017

Charles E Argoff

series ordinal

2

1 reference

24 August 2017

1 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

71

1 reference

24 August 2017

557-589

1 reference

24 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/11588940-000000000-00000

24 August 2017

0 references

cites work

Clinical characteristics and economic costs of patients with painful neuropathic disorders

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

New Insights Into Diabetic Polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The spectrum of neuropathy in diabetes and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Vascular risk factors and diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Elevated triglycerides correlate with progression of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Diabetic neuropathies: a statement by the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Diabetic neuropathy: mechanisms to management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Follow-up report on the diagnosis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Diabetic peripheral neuropathy and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Development of a neuropathic pain questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Diabetic somatic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Pharmacotherapy of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Cutaneous C-fiber pain abnormalities of fibromyalgia patients are specifically related to temporal summation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Epidermal nerve fiber density: normative reference range and diagnostic efficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Diabetic neuropathy and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Oxidative stress in the pathogenesis of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Effects of polyol pathway hyperactivity on protein kinase C activity, nociceptive peptide expression, and neuronal structure in dorsal root ganglia in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The potential role of thiamine (vitamin B1) in diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Poly(ADP-ribose) polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Role of advanced glycation end products and their receptors in development of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Understanding RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Diabetes-induced alterations in calcium homeostasis in sensory neurones of streptozotocin-diabetic rats are restricted to lumbar ganglia and are prevented by neurotrophin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Neurotrophin-3 prevents mitochondrial dysfunction in sensory neurons of streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Diabetic neuropathies: components of etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Voltage-gated sodium channel Nav1.6 is modulated by p38 mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Cellular and physiological effects of C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The effect of an aldose reductase inhibitor on the galactose-exposed rabbit lens

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Polymorphisms of the aldose reductase gene and susceptibility to diabetic microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Aldose reductase, still a compelling target for diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Sulfasalazine blocks the development of tactile allodynia in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Duloxetine vs. placebo in patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Gabapentin: a Ca2+ channel alpha 2-delta ligand far beyond epilepsy therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Antinociceptive effect of topiramate in models of acute pain and diabetic neuropathy in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

A pilot study of the beneficial effects of amantadine in the treatment of painful diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Spinal pharmacology of tactile allodynia in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Analgesic effect of dextromethorphan in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study With Long-Term Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled tri

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

A cost-utility comparison of four first-line medications in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Lacosamide: a review of preclinical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Modulation of P2X receptors in dorsal root ganglion neurons of streptozotocin-induced diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Effects of the endocannabinoid transport inhibitors AM404 and UCM707 on diabetic neuropathy in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Tocotrienols in health and disease: the other half of the natural vitamin E family

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Antioxidant properties of alpha-tocopherol and alpha-tocotrienol

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Transforming growth factor-beta induces cellular injury in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Brain-derived TNFalpha mediates neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588940-000000000-00000

Vitamin B12 may be more effective than nortriptyline in improving painful diabetic neuropathy

21 January 2018

1 reference

12 December 2020

Natural history of diabetic gastroparesis

1 reference

12 December 2020

Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial

1 reference

12 December 2020

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study

1 reference

12 December 2020

The prevalence of symptoms of sensorimotor and autonomic neuropathy in Type 1 and Type 2 diabetic subjects

1 reference

12 December 2020

The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat

1 reference

12 December 2020

Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies

1 reference

12 December 2020

Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells

1 reference

12 December 2020

Review of the use of Topiramate for treatment of psychiatric disorders

1 reference

12 December 2020

Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats.

1 reference

12 December 2020

The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy

1 reference

12 December 2020

Pain assessment: global use of the Brief Pain Inventory

1 reference

12 December 2020

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

1 reference

12 December 2020

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy

1 reference

12 December 2020

Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats

1 reference

12 December 2020

Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey

1 reference

12 December 2020

Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors

1 reference

12 December 2020

Elevated serum transforming growth factor beta 1 level in primary lung cancer patients with finger clubbing

1 reference

12 December 2020

Possible role of lipid peroxidation in the induction of NF-kappa B and AP-1 in RFL-6 cells by crocidolite asbestos: evidence following protection by vitamin E

1 reference

12 December 2020

Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Capsaicin Study Group

1 reference

12 December 2020

Thermoreceptive innervation of human glabrous and hairy skin: a contact heat evoked potential analysis

1 reference

12 December 2020

Protective effect of adenosine in diabetic neuropathic pain is mediated through adenosine A1-receptors.

1 reference

12 December 2020

Resveratrol, a polyphenolic phytoalexin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats.

1 reference

12 December 2020

Increased responsiveness of sensory neurons in the saphenous nerve of the streptozotocin-diabetic rat.

1 reference

12 December 2020

Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats. A possible mechanism of chronic diabetic neuropathic pain.

1 reference

12 December 2020

NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain

1 reference

12 December 2020

Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy.

1 reference

12 December 2020

Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy

1 reference

12 December 2020

Changes of sodium channel expression in experimental painful diabetic neuropathy

1 reference

12 December 2020

The association of aldose reductase gene (AKR1B1) polymorphisms with diabetic neuropathy in adolescents

1 reference

12 December 2020

Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats

1 reference

12 December 2020

Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain

1 reference

12 December 2020

Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats

1 reference

12 December 2020

Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group

1 reference

12 December 2020

Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription.

1 reference

12 December 2020

Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat

1 reference

12 December 2020

Tegretol in the treatment of diabetic neuropathy

1 reference

12 December 2020

The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy

1 reference

12 December 2020

Activation of the RAGE pathway: a general mechanism in the pathogenesis of polyneuropathies?

1 reference

12 December 2020

Abnormal Function of C-Fibers in Patients with Diabetic Neuropathy

1 reference

12 December 2020

Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms

1 reference

12 December 2020

Patterns of contact heat evoked potentials (CHEP) in neuropathy with skin denervation: Correlation of CHEP amplitude with intraepidermal nerve fiber density

1 reference

12 December 2020

Pathological mechanisms involved in diabetic neuropathy: can we slow the process?

1 reference

12 December 2020

Nitric oxide in damage, disease and repair of the peripheral nervous system.

1 reference

12 December 2020

Diabetic neuropathies

1 reference

12 December 2020

Decline in neurophysiological function after 7 years in an adolescent diabetic cohort and the role of aldose reductase gene polymorphisms

1 reference

12 December 2020

Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes

1 reference

12 December 2020

A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats

1 reference

12 December 2020

Targeted delivery of nerve growth factor via fibronectin conduits assists nerve regeneration in control and diabetic rats

1 reference

12 December 2020

Neuropathic pain symptoms relative to overall pain rating

1 reference

12 December 2020

Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. American Diabetes Association

1 reference

12 December 2020

Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2

1 reference

12 December 2020

Antidepressants for neuropathic pain

1 reference

12 December 2020

Pathogenesis of diabetic neuropathy.

1 reference

12 December 2020

Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).

1 reference

12 December 2020

Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain.

1 reference

12 December 2020

New and emerging treatment options for neuropathic pain

1 reference

12 December 2020

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)

1 reference

12 December 2020

Efficacy of Alrestatin, An Aldose Reductase Inhibitor, in Human Diabetic and Nondiabetic Lenses

1 reference

12 December 2020

Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat

1 reference

12 December 2020

Receptor for advanced glycation end products and its ligands: initiators or amplifiers of joint inflammation--a bit of both?

1 reference

12 December 2020

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

10.2165/11588940-000000000-00000

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21443281